Since its founding, the SWCRF has provided nearly $100 million in funding to more than 200 science investigators at top research institutions all over the world.

Through our Institute Without Walls™, we have funded research that studies cancers of the blood (leukemia and lymphoma), brain, breast, colon, liver, lung, pancreas, and prostate along with programs that study childhood cancers, cancer cell reprogramming, and tumor dormancy. Below is a highlight of our research areas and the scientists we have funded.

Tumor Dormancy

- Julio A. Aguirre-Ghiso, Ph.D., Icahn School of Medicine at Mount Sinai

- Eduardo F. Farias, Ph.D., Icahn School of Medicine at Mount Sinai

- Emily Bernstein, Ph.D., Icahn School of Medicine at Mount Sinai

Brain Cancer

- Albert S. Baldwin Jr., Ph.D., University of North Carolina, Chapel Hill

- Kevan Shokat, Ph.D., University of California, San Francisco

- William Weiss, M.D., Ph.D., University of California, San Francisco

Cancer Stem Cells

- Margaret Goodell, Ph.D., Baylor College of Medicine

Developing Epigenetic Therapy

- Stephen Baylin, M.D., Johns Hopkins University

- Robert A. Casero, Ph.D., Johns Hopkins University

- Sai-Juan Chen, M.D., Ph.D., Shanghai Institute of Hematology

- Zhu Chen, M.D., PhD., Shanghai Institute of Hematology

- Jonathan D. Licht, M.D., University of Florida Health

- Alexander MacKerrell, Ph.D., University of Maryland

- Ari Melnick, M.D., Weill Cornell Medical Center

- Wilson Miller, M.D., Ph.D., Jewish General Hospital

- Gilbert Privé, Ph.D., University of Toronto

- Ruibao Ren, M.D., Ph.D., Brandeis University

- Samuel Waxman, M.D., Mount Sinai School of Medicine

- Yue Xiong, Ph.D., University of North Carolina, Chapel Hill

- Arthur Zelent, Ph.D., Sylvester Comprehensive Cancer Center, University of Miami

- Ming-Ming Zhou, Ph.D., Mount Sinai School of Medicine

Blood Malignancies

- Sai-Juan Chen, M.D., Ph.D., Shanghai Institute of Hematology

- Zhu Chen, M.D., PhD., Shanghai Institute of Hematology

- Yongkui Jing, Ph.D., Mount Sinai School of Medicine

- Ross Levine, M.D., Memorial Sloan-Kettering Cancer Center

- Jonathan D. Licht, M.D., University of Florida Health

- Ari Melnick, M.D., Weill Cornell Medical Center

- Ruibao Ren, M.D., Ph.D., Brandeis University

- Yang Shen, Ph.D., Shanghai Institute of Hematology

- Yue Xiong, Ph.D., University of North Carolina, Chapel Hill

- Jiang Zhu, Ph.D., Shanghai Institute of Hematology

Childhood and Young Adult Cancers

- John Crispino, Ph.D., Northwestern University

- Christopher A. French, M.D., Brigham & Women's Hospital

- Shai Izraeli, M.D., Tel Aviv University

- Kevan Shokat, Ph.D., University of California, San Francisco

Lung Cancer

- Duane Compton, Ph.D., Geisel School of Medicine/Dartmouth

- Ethan Dmitrovsky, M.D., MD Anderson Cancer Center

- Cynthia Zahnow, Ph.D., Johns Hopkins University

Colon Cancer

- Ronald M. Evans, Ph.D., Salk Institute

Breast Cancer

- Jayanta Debnath, M.D., University of California, San Francisco

- Doris Germain, Ph.D., Mount Sinai School of Medicine

- Samuel Waxman, M.D., Mount Sinai School of Medicine

- Robert A. Weinberg, Ph.D., Whitehead Institute for Biomedical Research

- Garry P. Nolan, Ph.D., Stanford University School of Medicine

Pancreatic Cancer

- Nabeel Bardeesy, Ph.D., Massachusetts General Hospital

- Gregory David, Ph.D., NYU School of Medicine

Liver Cancer

- Josep M. Llovet, M.D., Mount Sinai School of Medicine

- Samuel Waxman, M.D., Mount Sinai School of Medicine